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Tests based on bacteriophage replication enable rapid screening of Mycobacterium tuberculosis for drug
resistance. We describe a novel broth-based colorimetric method for detecting phage replication. When clinical
isolates were tested by this novel method, high concordance was observed with both the traditional phage assay
and gene mutation analysis for detection of resistance to rifampin.
The emergence of drug-resistant tuberculosis that cannot be
cured using standard drug regimens is a serious threat to the
control of the disease. Early detection of drug resistance is
desirable both for the patient and to aid control measures.
Molecular tests are available for rapid detection of resistance
to rifampin. However, cost restraints and the lack of infrastruc-
ture have prevented their implementation in resource-poor
settings. Monitoring for drug resistance in most countries
where tuberculosis is endemic remains culture based and is
slow and time-consuming. We have previously reported a
rapid, low-cost, phage-based assay for screening isolates for
susceptibility to antituberculosis drugs (12). Continued repli-
cation and production of progeny phage in the presence of
drug are indicative of a drug-resistant strain of bacteria. A
96-microwell plate version of the assay is reported to have high
sensitivity and specificity for detecting resistance to rifampin
(4, 7, 9) Progeny phage is detected by the traditional method of
plating aliquots on a lawn of fast-growing indicator bacteria
and observing plaque formation (1). We describe here a novel
colorimetric end point for the assay using the redox dye 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
(Sigma-Aldrich, Poole, United Kingdom) and its application to
a panel of 96 clinical isolates of Mycobacterium tuberculosis.
Bacteriophage stocks. The bacteriophage used in these stud-
ies, mycobacteriophage D29, infects a wide range of mycobac-
teria, including members of the M. tuberculosis complex (3).
Stocks may be easily maintained in the laboratory by propaga-
tion on a lawn of fast-growing mycobacteria such as Mycobac-
terium smegmatis mc2155 (William R. Jacobs, Jr., Howard
Hughes Medical Institute, Albert Einstein College of Medi-
cine, New York, NY). Plates were prepared by adding 10%
(vol/vol) stationary-phase M. smegmatis culture to 1.5% agar in
Luria-Bertani broth (Becton Dickinson, Sparks, MD) in
90-mm petri dishes (6). The plates were inoculated by spread-
ing 100 l of mycobacteriophage D29 (London School of
Hygiene & Tropical Medicine, London, United Kingdom) at
approximately 4 103 PFU/ml in Middlebrook 7H9 broth with
1 mM calcium chloride. Following overnight incubation at
37°C, 10 ml of Middlebrook 7H9 broth with 10% OADC (oleic
acid-albumin-dextrose-catalase) and 1 mM calcium chloride
was added to the plate. Following a further overnight incuba-
tion at 37°C, the broth was collected and filtered though a
sterile 0.4-m filter to remove bacteria and debris. The filtrate
containing the phage stock was stored at 4°C with the addition
of 0.1% sodium azide (Sigma-Aldrich, Poole, United King-
dom). Phage stocks containing 109 to 1010 PFU/ml were pre-
pared by this method. The titer of the phage stock was estab-
lished by plating serial dilutions on a lawn of M. smegmatis
followed by overnight incubation at 37°C. Enumeration of the
resulting PFU enabled back-calculation of the concentration of
PFU in the stock suspension.
Phage drug resistance assay. Testing of the two detection
methods was performed in parallel on duplicate samples at
final drug concentrations of 2 and 10 g/ml. All manipulations
involving M. tuberculosis were performed in a class I microbi-
ological safety cabinet. Bacteria from Lowenstein-Jensen agar
slopes were suspended in Middlebrook 7H9 broth supple-
mented with OADC (Becton Dickinson, Sparks, MD) and 1
mM calcium chloride, as described previously (6). Bacterial
suspension samples (75 l) were placed in the wells of a 96-
microwell plate (Greiner Labortechnik, Stonehouse, United
Kingdom) containing equal volumes of drug at the appropriate
dilution and a zero-drug control. Following overnight incuba-
tion at 37°C, 50 l of a stock suspension of mycobacteriophage
D29 was added to give a final concentration of 3  107/ml, and
the infection was allowed to proceed. After incubation at 37°C
for 90 min, any residual extracellular bacteriophage was killed
during the latent phase of the infection. Different virucidal
agents were used for the two detection methods.
MTT assay. For the colorimetric MTT detection method,
0.3% sulfuric acid (75 l) was added to each well (2). Plates
were left for 5 min at room temperature to allow the acid to kill
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any extracellular phage and then neutralized by the addition of
25 l of 0.24 M sodium hydroxide. To detect bacteriophage
replication, test samples (50 l) were transferred to a fresh
96-well microplate, with each well containing 200 l of a sta-
tionary-phase culture of M. smegmatis mc2155 diluted 1:5 in
supplemented Middlebrook 7H9 broth. Following overnight
incubation at 37°C, each well received 20 l of MTT solution
(2 g/ml in water). The color of each well was recorded after
an additional 16 h of incubation. MTT is a tetrazolium dye that
upon reduction changes in color from yellow to purple. Growth
of M. smegmatis in the wells results in a color change, whereas
for samples where bacterial proliferation is prevented by the
lytic action of the phage, no such change is observed. Purple
coloration in those samples treated with rifampin indicates that
phage replication has not proceeded and that the isolate is
susceptible to the drug. Yellow coloration in samples exposed
to drug indicates successful phage replication and a rifampin-
resistant isolate. Growth of M. smegmatis provides a sufficient
substrate for easy visual determination, and further treatment
to solubilize the formazan dye products was not required.
Plaque assay. For the plaque assay, 100 ml of 30 mM ferrous
ammonium sulfate (Sigma-Aldrich, Poole, Dorset, United
Kingdom) was added to each well to inactivate extracellular
phage as described previously (8). Indicator plates containing a
lawn of M. smegmatis mc2155 were prepared as described
above. The indicator plates were stored in the refrigerator and
dried for 1 h at 37°C prior to use, to remove surface moisture
(6). Ten-microliter aliquots of each sample were placed on the
agar surface, and plaques were observed following overnight
incubation at 37°C. A strain was classified as susceptible if
plaques in the lawn were observed for the zero-drug control
samples but not for the drug-treated samples. Strains were
designated as resistant if plaques were observed for the drug-
treated samples. Up to 12 samples were spotted onto the in-
dicator plate, eight petri dishes being required for a 96-well
assay.
Sequence analysis. All isolates were also investigated for
mutations predictive of resistance in an 81-bp region of the
rpoB gene as described by Telenti et al. (11). Sequencing was
performed at the Genome Research Centre at the London
School of Hygiene & Tropical Medicine using a BigDye ter-
minator cycle sequencing kit (version 3.1; Applied Biosystems,
Foster City, CA). The primers used were those described by
Ohno et al. (10). The sequences obtained were compared to
those of the M. tuberculosis H37Rv RNA polymerase beta
subunit gene (rpoB; GenBank accession no. U12205) using the
DNAStar MegAlign program (DNAStar, Madison, WI).
The results are shown in Table 1. Ten isolates were found to
be resistant, and 70 were found to be susceptible by all three
methods. The MTT phage test demonstrated high concor-
dance (97.9%) with both the plaque phage test and sequence
analysis, when tested with rifampin at 10 g/ml. When a
2-g/ml concentration of drug was used, the level of agreement
was reduced to 90.6% with the plaque test and 89.6% with
sequence analysis. If the results from the sequence analysis are
considered the “gold standard” for assessing resistance, the
estimated sensitivity, specificity, positive predictive, and nega-
tive predictive values when rifampin was used at 10 g/ml were
90.9, 98.8, 90.9 and 98.8%, respectively, for the MTT test and
90.9, 96.5, 76.9, and 98.9%, respectively, for the plaque test. In
comparison to sequence analysis, the MTT test produced fewer
apparent false-positive results than the plaque test. This sug-
gests that the colorimetric phage assay may offer improved
accuracy over plaque-based methods. However, further testing
and thorough investigation of discrepant results will be re-
quired to substantiate this supposition. For implementation in
resource-poor laboratories, new technology should be robust
and affordable. In this respect, the microwell phage assay does
not require investment in sophisticated equipment other than
that utilized for handling cultures of M. tuberculosis. For pro-
cessing a batch of 30 isolates, the cost of reagents was esti-
mated to be less than $1 per isolate tested (tax and overhead
costs excluded; goods were purchased via the London Univer-
sities Purchasing Consortium). The microwell phage assay en-
ables high-throughput screening of M. tuberculosis isolates for
drug resistance. For more rapid detection of drug-resistant
disease, it may be possible to use a phage-based test to detect
drug resistance directly in clinical specimens. Preliminary re-
ports from Peru suggest that resistance to rifampin may be
detected in sputum specimens found positive for acid-fast
bacilli by smear microscopy (5). However, assessment of the
utility of such an approach awaits further data on its sensitivity
and specificity.
In conclusion, the MTT colorimetric method is convenient
to use and, when used with rifampin at 10 g/ml, may provide
a rapid means of differentiating rifampin-susceptible and -re-
sistant isolates of M. tuberculosis. The method avoids prepara-
tion of indicator plates, minimizing both reagent and labor
requirements. The multiwell format permits semiautomation
by use of multichannel pipettes and facilitates the handling of
large numbers of samples. Further studies are required to
further validate this assay and to investigate its potential for
detecting resistance to other antiuberculosis drugs.
TABLE 1. Susceptibility profiles of 96 clinical isolates of M. tuberculosis
tested by the MTT colorimetric phage test, a traditional plaque-based
test, and sequence analysis of an 81-bp region of the rpoB gene
Isolate(s)
Susceptibility profilea
MTT phage test Plaque phage test Sequence
analysis2 g/mlb 10 g/ml 2 g/ml 10 g/ml
12375 R R R R Asp516Tyr
527 R R R R His526Asp
16122 R R R R His526Asp
16446 R R R R His526Asp
17034 R R R R Ser531Leu
889 R R R R His526Tyr
33 R R R R Ser531Leu
521 R R R R Ser531Leu
10816 R R R R Ser531Leu
12108 R R R R Ser531Leu
17020 S S S S His526Asn
17053 R R R R WT
12015 R S R R WT
11720 S S R R WT
4 isolates R S R S WT
5 isolates S S R S WT
3 isolates R S S S WT
70 isolates S S S S WT
a R, resistant; S, susceptible; WT, wild type.
b Final concentration of drug.
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